M Díaz-Sánchez, J C Martínez-Castrillo. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Articulation Disorders/drug therapyArticulation Disorders/etiologyArticulation Disorders/physiopathologyBotulinum Toxins, Type A/administration & dosageDysarthria/drug therapyDysarthria/etiologyDysarthria/physiopathologyDystonic Disorders/drug therapyDystonic Disorders/physiopathologyFemaleHumansMandible/physiopathologyMasticatory Muscles/drug effectsMasticatory Muscles/innervationMasticatory Muscles/physiopathologyMiddle AgedMouth/physiopathologyNeuromuscular Agents/administration & dosageOccupational Diseases/drug therapyOccupational Diseases/physiopathologySpeech/drug effectsSpeech/physiologyTongue/drug effectsTongue/innervationTongue/physiopathologyTreatment Outcome
Substances: See more » Neuromuscular AgentsBotulinum Toxins, Type A
Year: 2008 PMID: 18481036 DOI: 10.1007/s00415-008-0716-y
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849